Companies: 10,795·Total market cap: $144.5T
BioMark Diagnostics Inc.

BioMark Diagnostics Inc.

BMKDFOTCHealthcare● Active
$0.40
$-0.02(-5.87%)
Market Cap$41930995
P/E Ratio—
52W High$0.5044
52W Low$0.2034
Overview
Stock ranking:Medical - Diagnostics & Research·Healthcare·View All Market Cap Rankings →

BioMark Diagnostics Inc. (BMKDF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · BMKDF · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.02bmkdf eps ttm · bmkdf earnings per shareEarnings history
PE Ratio (TTM)—bmkdf pe ratio ttm · bmkdf price to earningsPE Ratio deep dive
Revenue (TTM)91765.00bmkdf revenue ttm · bmkdf annual revenueFull revenue history
Dividend YieldNo Dividenddoes bmkdf pay dividends · bmkdf dividend yieldDividend history
Shares Outstanding90.9Mbmkdf shares outstanding · bmkdf floatShares outstanding history
Next EarningsTBAbmkdf earnings date · bmkdf next earningsEarnings history

Explore BioMark Diagnostics Inc. Data

bmkdf stock data · financials
Market Cap$41.9Mbmkdf market cap · bmkdf valuation
Analyst Forecast—
DividendsNo Dividenddoes biomark diagnostics inc. pay dividends · bmkdf dividend yield
Revenue$154216-5.52%biomark diagnostics inc. annual revenue · bmkdf revenue
EarningsEPS $-0.02-19.76%bmkdf earnings · bmkdf eps
PE Ratio—bmkdf pe ratio · bmkdf price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$154216.00▼ 5.52% YoY
202320242025
biomark diagnostics inc. revenue · bmkdf revenue 2025
FY 2025Net Income-$1.9M▼ 35.02% YoY
202320242025
biomark diagnostics inc. net income · bmkdf profit 2025
FY 2025EPS$-0.02▼ 19.76% YoY
202320242025
bmkdf eps · biomark diagnostics inc. earnings per share 2025
TTM:Revenue: $91765.00Net Income: -$1.7MEPS: $-0.02View income statement →

Stock Performance

Full History
1D-5.87%
1W-5.87%
1M-2.66%
3M-8.15%
YTD+16.36%
1Y+72.24%
5Y+29.58%

About BioMark Diagnostics Inc.

CEORashid Ahmed Maula Bux
IPO DateMar 23, 2015
Employees9
CountryCA
Websitebiomarkdiagnostics.com

BioMark Diagnostics Inc. is an oncology-focused firm that develops sophisticated diagnostic tools for cancer. These solutions are designed to aid in the identification of the disease, its ongoing moni…

Medical - Diagnostics & ResearchHealthcareOTCCA

what is biomark diagnostics inc. · bmkdf stock overview · biomark diagnostics inc. company profile · who is biomark diagnostics inc. ceo · bmkdf OTC · biomark diagnostics inc. headquarters · biomark diagnostics inc. business segments

About Stock Overview & Key Data

BioMark Diagnostics Inc. (BMKDF) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since Mar 23, 2015. As of the latest trading session, BMKDF stock price is $0.40, with a market capitalization of $41.9M. The stock has returned +72.24% over the past 12 months and +16.36% year-to-date.

In fiscal year 2025, BioMark Diagnostics Inc. reported revenue of $154216.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, BioMark Diagnostics Inc. (BMKDF) stock price is $0.40. The stock is traded on OTC under the ticker symbol BMKDF. The 52-week range is $0.20 – $0.50.

BMKDF stock priceBMKDF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice